NITROFURANTOIN SODIUM bulk active fine chemical vendors

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
ChemBridge	⤷ Get Started Free	5492202	⤷ Get Started Free
Sigma-Aldrich	⤷ Get Started Free	N7878_SIGMA	⤷ Get Started Free
NovoSeek	⤷ Get Started Free	6604200	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: August 3, 2025

Introduction

Nitrofurantoin sodium is a broad-spectrum antimicrobial agent primarily employed in the treatment and prevention of urinary tract infections (UTIs). As a critical active pharmaceutical ingredient (API), its sourcing significantly impacts manufacturing quality, regulatory compliance, and supply chain stability in pharmaceutical production. This article provides a comprehensive overview of key bulk API sources for nitrofurantoin sodium, focusing on reputable manufacturers, sourcing considerations, global supply dynamics, and regulatory standards.

Overview of Nitrofurantoin Sodium

Nitrofurantoin sodium is a water-soluble salt form of nitrofurantoin, which belongs to the nitrofuran class. Its mechanism involves inhibiting bacterial enzyme systems, resulting in bactericidal activity against various pathogens commonly implicated in urinary infections, including Escherichia coli, Enterococcus spp., and Staphylococcus saprophyticus. Regulatory authorities such as the U.S. FDA, EMA, and WHO require strict quality controls for its raw material, emphasizing purity, stability, and consistent bioactivity [1].

Global API Manufacturing Landscape

The production of nitrofurantoin sodium API is concentrated among a handful of manufacturing hubs across Asia, Europe, and North America. Asia, particularly China and India, dominates the API market due to cost efficiencies, extensive infrastructure, and mature regulatory frameworks. European and North American manufacturers often focus on higher-grade APIs with rigorous compliance and quality assurance programs to meet stringent regulatory demands.

Key API Suppliers for Nitrofurantoin Sodium

1. Chinese Manufacturers

China is the largest supplier of generic APIs worldwide, including nitrofurantoin sodium. Several state-of-the-art facilities operate under Good Manufacturing Practice (GMP) certifications, offering competitive pricing and flexible supply options.

Hubei Huishen Pharmaceutical Co., Ltd.: Known for their extensive portfolio of antibiotics and nitrofuran derivatives, this manufacturer supplies high-purity nitrofurantoin sodium suitable for pharmaceutical applications. They maintain GMP certification and adhere to strict quality standards [2].
Zhejiang Hisun Pharmaceutical Co., Ltd.: Engaged in the synthesis of APIs with a focus on pipeline expansion for antibiotics, including nitrofurantoin sodium. Their products comply with CE and FDA standards, emphasizing quality control and stability testing [3].
Shandong Xinhua Pharmaceutical Co., Ltd.: Offers API manufacturing with emphasis on pharmaceutical grade nitrofurantoin sodium, with facilities certified for domestic and export markets.

2. Indian Manufacturers

India's API industry offers high-quality nitrofurantoin sodium with a focus on pharmaceutical-grade standards, driven by a robust regulatory environment and export capacity.

Aurobindo Pharma Ltd.: One of India's leading API producers, Aurobindo offers GLP-compliant nitrofurantoin sodium suitable for formulations globally. Their manufacturing sites are GMP certified and conform to global regulatory expectations [4].
Cipla Limited: Known for a diverse portfolio of antibiotics, Cipla supplies pharmaceutical-grade nitrofurantoin sodium with rigorous quality controls, emphasizing purity and bioavailability.
Mylan Laboratories: Active in the production of antibiotics, Mylan provides APIs with high specifications, adhering to USFDA and EMA standards, ensuring consistency and quality assurance.

3. European and North American Suppliers

While less prevalent due to higher costs, these suppliers emphasize regulatory compliance, quality management, and high-grade APIs.

Sterling Pharma Solutions (UK): Specializes in GMP manufacturing of APIs, including nitrofurantoin sodium, with a focus on custom synthesis and regulatory compliance [5].
BASF SE (Germany): Offers pharmaceutical-grade APIs with a focus on high-purity standards and extensive quality documentation, catering to clients across Europe and North America.
Lupin Limited (India, with global distribution): Offers high-quality APIs with comprehensive regulatory documentation, serving global markets including the US and Europe.

Sourcing Considerations

Regulatory Compliance and Quality Standards

Manufacturers must comply with current Good Manufacturing Practices (cGMP), ISO certifications, and other relevant standards. Suppliers providing APIs for international markets should supply Certificates of Suitability (CE) and Drug Master Files (DMF), ensuring regulatory acceptance in major jurisdictions such as the US, EU, and Japan [6].

Purity and Specifications

Nitrofurantoin sodium APIs should meet rigorous specifications including purity (>98%), low residual solvents, appropriate polymorphic form, and stability. Suppliers providing comprehensive testing reports and stability data facilitate regulatory approval processes.

Supply Chain Stability

Given the essential role of nitrofurantoin sodium in UTI treatment, resilient supply chains are critical. Partnering with manufacturers with diversified production sites, robust logistics, and inventory management reduces risk of shortages.

Pricing and Lead Times

Asia-based suppliers typically offer cost-effective options, but longer lead times and logistical challenges can influence procurement strategies. European and North American sources may command premium pricing but offer advantages concerning regulatory clearance and supply chain assurance.

Regulatory and Quality Assurance Landscape

The global pharmaceutical industry increasingly emphasizes compliance and transparency. As such, manufacturers' adherence to GMP, ISO standards, and regulatory submissions influence sourcing decisions. Suppliers that maintain robust documentation, provide detailed analytical data, and demonstrate consistent quality are preferred partners for pharma companies.

Emerging Trends in API Sourcing

Shift Towards Sustainable and Green Chemistry

Manufacturers adopting environmentally friendly synthesis routes and reducing hazardous waste generation are gaining preference. These practices align with FDA and EMA environmental standards and improve supply chain sustainability.

Digital Documentation and Transparency

An increasing number of suppliers use digital platforms for real-time batch tracking, certification sharing, and quality data dissemination, enabling transparent sourcing decisions.

Growth of Contract Manufacturing and API Brokers

Third-party contract manufacturing organizations (CMOs) and API brokers are increasingly facilitating procurement, offering access to multiple suppliers, quality assurance services, and flexible buying options.

Regulatory Considerations for Sourcing

Procurement of nitrofurantoin sodium APIs must consider regulatory dossiers, registration status, and compliance certifications. Buyers should validate suppliers’ Certificates of Analysis (CoA), Batch Production Records, and Certificates of Suitability (CE) or Drug Master Files (DMF). Ensuring supplier prequalification reduces downstream regulatory risks.

Supply Chain Risks and Mitigation

Geopolitical Risks: Trade restrictions, tariffs, or geopolitical conflicts may disrupt supply chains, necessitating diversification of sourcing bases.
Quality Variability: Variance in quality standards among suppliers requires rigorous quality audits and qualification procedures.
Price Fluctuations: Market demand and raw material costs influence pricing; long-term agreements can secure favorable terms.

Conclusion

The sourcing landscape for nitrofurantoin sodium API is dynamic and complex, guided by regulatory, quality, and supply considerations. Leading Chinese and Indian manufacturers provide cost-effective options with GMP compliance, while European and North American suppliers cater to clients demanding higher regulatory assurance. Strategic sourcing, including supplier qualification, quality assurance, and supply chain resilience, is imperative for pharmaceutical companies seeking a reliable supply of high-purity nitrofurantoin sodium API.

Key Takeaways

Global sourcing options range from Asia-based manufacturers offering cost-efficient APIs to European and North American suppliers emphasizing quality and regulatory compliance.
Regulatory documentation and certifications such as GMP, CE, and DMF are critical when selecting suppliers for international markets.
Purity, stability, and specifications must meet stringent pharmaceutical standards; comprehensive analytical data are essential.
Supply chain resilience can be improved through diversification of suppliers and geographical spread, mitigating risk of disruptions.
Emerging trends in green chemistry and digital transparency are shaping future API sourcing strategies.

FAQs

1. What are the primary considerations when sourcing nitrofurantoin sodium API?
Regulatory compliance, quality standards, purity, supply chain stability, and cost are the chief considerations. Manufacturers must adhere to GMP and provide detailed documentation for regulatory approval.

2. Which countries dominate the manufacturing of nitrofurantoin sodium?
China and India are the leading producers, with European and North American companies focusing on high-regulatory-standard APIs.

3. How does regulatory compliance influence API sourcing decisions?
Regulatory compliance ensures the API meets safety, efficacy, and quality standards required by authorities like the FDA and EMA, reducing approval hurdles and potential liabilities.

4. Are there sustainability trends affecting nitrofurantoin sodium API production?
Yes, manufacturers adopting green chemistry practices and minimizing environmental impact are increasingly favored, aligning with global regulatory and corporate responsibility standards.

5. How can pharmaceutical companies mitigate supply chain risks for nitrofurantoin sodium API?
Diversifying supplier sources, conducting rigorous vendor assessments, maintaining inventory buffers, and establishing long-term contracts help mitigate risks.

Sources

[1] U.S. Food and Drug Administration. (2022). Guidance for Industry: Manufacturing and Quality Control Guidelines for Nitrofuran Derivatives.
[2] Hubei Huishen Pharmaceutical Co., Ltd. Official Website.
[3] Zhejiang Hisun Pharmaceutical Co., Ltd. Annual Report 2021.
[4] Aurobindo Pharma Ltd. API Product Portfolio.
[5] Sterling Pharma Solutions. GMP API Manufacturing Capabilities.
[6] European Medicines Agency. Guidelines on the requirements for quality documentation for human medicinal products.

Bulk Pharmaceutical API Sources for NITROFURANTOIN SODIUM